Get the Stockscreener App
350.30
0.06%
-0.20
After Hours:
350.30
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $350.30, with a volume of 735.79K.
It is down -0.06% in the last 24 hours and down -2.09% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
See More
Previous Close:
$350.50
Open:
$351.37
24h Volume:
735.79K
Relative Volume:
0.65
Market Cap:
$97.93B
Revenue:
$216.01B
Net Income/Loss:
$3.71B
P/E Ratio:
19.76
EPS:
17.7276
Net Cash Flow:
$7.96B
1W Performance:
+2.52%
1M Performance:
-2.09%
6M Performance:
-0.79%
1Y Performance:
+18.97%
1-Day Range:
$349.69
$354.99
1-Week Range:
$338.69
$354.99
52-Week Range:
$253.95
$370.82
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Livforsakringsbolaget Skandia Omsesidigt Has $12.37 Million Position in The Cigna Group (NYSE:CI) - MarketBeat
Perpetual Ltd Lowers Position in The Cigna Group (NYSE:CI) - MarketBeat
Cigna Says NJ Plastic Surgeons Fraudulently Billed $8.5M - Law360
See the list: 7 plans, compared to 38 last year, receive 5 stars in the MA Star Ratings - Healthcare Finance News
Cigna Group stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Brendel Financial Advisors LLC Lowers Stake in The Cigna Group (NYSE:CI) - MarketBeat
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias - MSN
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias - MarketWatch
UnitedHealth, CVS, Cigna accuse FTC Chair Khan of 'serious bias' against PBMs - MSN
UnitedHealth, CVS, Cigna accuse FTC Chair Khan of 'serious bias' against PBMs - Seeking Alpha
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias - The Wall Street Journal
CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case - Reuters
CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case - XM
CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case - U.S. News & World Report
Low personal vitality linked to delaying treatment and slower recovery – Cigna - Health & Protection
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case - CNBC
Kesler Norman & Wride LLC Purchases Shares of 1,998 The Cigna Group (NYSE:CI) - MarketBeat
ON THE MOVE CIGNA NAMES CALEB FOWLER TO NEW POSTS - JOC.com
3 Dividend Growth Stocks Set to Supercharge Your Portfolio - Benzinga
Is The Cigna Group (CI) the Top Pick in Leon Cooperman’s Stock Portfolio? - Insider Monkey
Is The Cigna Group (CI) the Top Pick in Leon Cooperman’s Stock Portfolio? - Yahoo Finance
Cigna Group (CI): One of the Best Stocks to Buy According to Larry Robbins - Insider Monkey
Cigna Group (CI): One of the Best Stocks to Buy According to Larry Robbins - Yahoo Finance
SG Americas Securities LLC Sells 45,590 Shares of The Cigna Group (NYSE:CI) - MarketBeat
Handelsbanken Fonder AB Has $26.75 Million Stake in The Cigna Group (NYSE:CI) - MarketBeat
The Cigna Group (CI): Diversified Services and Strategic Growth Driving Success - Insider Monkey
The Cigna Group (CI): Diversified Services and Strategic Growth Driving Success - Yahoo Finance
Canandaigua National Bank & Trust Co. Trims Stake in The Cigna Group (NYSE:CI) - MarketBeat
Cigna Corporation (CI): A Buzzing AI Health Stock to Add to Your Portfolio - Insider Monkey
Cigna Corporation (CI): A Buzzing AI Health Stock to Add to Your Portfolio - Yahoo Finance
The Cigna Group (NYSE:CI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Cigna Group stock rises Friday, still underperforms market - MarketWatch
Is The Cigna Group (NYSE:CI) The Top Goldman Sachs Fund Manager Stock Pick? - Insider Monkey
Is The Cigna Group (NYSE:CI) The Top Goldman Sachs Fund Manager Stock Pick? - Yahoo Finance
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
HBW Advisory Services LLC Cuts Holdings in The Cigna Group (NYSE:CI) - MarketBeat
Cigna Long-Term Disability Guide 2024 | How to Apply & Claim Support - Samfiru Tumarkin LLP
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000% - Benzinga
CIThe Cigna Group Latest Stock News & Market Updates - StockTitan
Top Stock Movers Now: Intel, Microsoft, Amazon, Cigna, and More - MSN
4 examples of how Cigna Healthcare’s customer service team goes above and beyond to help members - Cigna Newsroom
The Cigna Group's Third Quarter 2024 Earnings Release Details - Quantisnow
Jefferies Upgrades Cigna Group (CI) - MSN
Mattson Financial Services LLC Buys Shares of 8,533 The Cigna Group (NYSE:CI) - MarketBeat
The Cigna Group's Third Quarter 2024 Earnings Release Details - StockTitan
The Cigna Group (BSP:C1IC34) Dividends per Share : R$4.72 (TTM As of Jun. 2024) - GuruFocus.com
NewEdge Advisors LLC Buys 5,224 Shares of The Cigna Group (NYSE:CI) - MarketBeat
10 Wonderful Stocks to Buy Now at a Fair Price - Insider Monkey
Health insurers unveil Medicare Advantage plans for 2025 - Reuters
Americans report slightly higher vitality for first time since 2022, Cigna study finds - BenefitsPro
Cantor Fitzgerald Reiterates "Overweight" Rating for The Cigna Group (NYSE:CI) - MarketBeat
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cigna Group Stock (CI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DeLaney William J III | Director |
Aug 19 '24 |
Option Exercise |
175.09 |
2,691 |
471,177 |
20,230 |
| DeLaney William J III | Director |
Aug 19 '24 |
Sale |
342.68 |
2,691 |
922,152 |
17,539 |
1.97%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):